Using GRADE Evidence to Decision frameworks to support the process of health policy-making: an example application regarding taxation of sugar-sweetened beverages.


Journal

European journal of public health
ISSN: 1464-360X
Titre abrégé: Eur J Public Health
Pays: England
ID NLM: 9204966

Informations de publication

Date de publication:
28 11 2022
Historique:
entrez: 29 11 2022
pubmed: 30 11 2022
medline: 1 12 2022
Statut: ppublish

Résumé

Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks are well-known tools that enable guideline panels to structure the process of developing recommendations and making decisions in healthcare and public health. To date, they have not regularly been used for health policy-making. This article aims to illustrate the application of the GRADE EtD frameworks in the process of nutrition-related policy-making for a European country. Based on methodological guidance by the GRADE Working Group and the findings of our recently published scoping review, we illustrate the process of moving from evidence to recommendations, by applying the EtD frameworks to a fictitious example. Sugar-sweetened beverage (SSB) taxation based on energy density was chosen as an example application. A fictitious guideline panel was convened by a national nutrition association to develop a population-level recommendation on SSB taxation aiming to reduce the burden of overweight and obesity. Exemplary evidence was summarized for each EtD criterion and conclusions were drawn based on all judgements made in relation to each criterion. As a result of the high priority to reduce the burden of obesity and because of the moderate desirable effects on health outcomes, but considering scarce or varying research evidence for other EtD criteria, the panel made a conditional recommendation for SSB taxation. Decision-makers may opt for conducting a pilot study prior to implementing the policy on a national level. GRADE EtD frameworks can be used by guideline panels to make the process of developing recommendations in the field of health policy more systematic, transparent and comprehensible.

Sections du résumé

BACKGROUND
Grading of Recommendations, Assessment, Development and Evaluation (GRADE) Evidence to Decision (EtD) frameworks are well-known tools that enable guideline panels to structure the process of developing recommendations and making decisions in healthcare and public health. To date, they have not regularly been used for health policy-making. This article aims to illustrate the application of the GRADE EtD frameworks in the process of nutrition-related policy-making for a European country.
METHODS
Based on methodological guidance by the GRADE Working Group and the findings of our recently published scoping review, we illustrate the process of moving from evidence to recommendations, by applying the EtD frameworks to a fictitious example. Sugar-sweetened beverage (SSB) taxation based on energy density was chosen as an example application.
RESULTS
A fictitious guideline panel was convened by a national nutrition association to develop a population-level recommendation on SSB taxation aiming to reduce the burden of overweight and obesity. Exemplary evidence was summarized for each EtD criterion and conclusions were drawn based on all judgements made in relation to each criterion. As a result of the high priority to reduce the burden of obesity and because of the moderate desirable effects on health outcomes, but considering scarce or varying research evidence for other EtD criteria, the panel made a conditional recommendation for SSB taxation. Decision-makers may opt for conducting a pilot study prior to implementing the policy on a national level.
CONCLUSIONS
GRADE EtD frameworks can be used by guideline panels to make the process of developing recommendations in the field of health policy more systematic, transparent and comprehensible.

Identifiants

pubmed: 36444109
pii: 6849910
doi: 10.1093/eurpub/ckac077
pmc: PMC9706117
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

iv92-iv100

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of the European Public Health Association.

Références

BMJ. 2016 Jun 28;353:i2016
pubmed: 27353417
Circulation. 2015 Aug 25;132(8):639-66
pubmed: 26124185
BMC Public Health. 2013 Nov 13;13:1072
pubmed: 24225016
Public Health Nutr. 2021 Nov;24(16):5550-5560
pubmed: 34218837
Curr Obes Rep. 2021 Mar;10(1):54-60
pubmed: 33471286
Public Health Nutr. 2022 Apr;25(4):1105-1117
pubmed: 34728000
J Evid Based Med. 2013 Feb;6(1):50-54
pubmed: 23557528
Obes Rev. 2020 Jul;21(7):e13020
pubmed: 32216045
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000844
pubmed: 30775012
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000848
pubmed: 30775013
Int J Behav Nutr Phys Act. 2019 Sep 4;16(1):78
pubmed: 31484538
BMJ. 2021 Mar 10;372:n254
pubmed: 33692200
BMJ. 2019 Jan 02;364:k4718
pubmed: 30602577
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
Obes Rev. 2019 Sep;20(9):1187-1204
pubmed: 31218808
Eur J Health Econ. 2021 Aug;22(6):905-915
pubmed: 33792852
Health Policy. 2020 Sep;124(9):919-931
pubmed: 32718790
Implement Sci. 2016 Dec 9;11(1):162
pubmed: 27938409
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
Public Health Nutr. 2016 Dec;19(17):3070-3084
pubmed: 27182835
J Clin Epidemiol. 2019 Jun;110:23-33
pubmed: 30779950
Obes Rev. 2011 Feb;12(2):131-41
pubmed: 20122135
BMJ. 2018 Jun 13;361:k2426
pubmed: 29898890
PLoS One. 2017 Mar 1;12(3):e0172277
pubmed: 28249003
PLoS One. 2015 Aug 05;10(8):e0124845
pubmed: 26244332
Am J Public Health. 2019 Feb;109(2):276-284
pubmed: 30571305
PLoS One. 2018 Aug 22;13(8):e0199337
pubmed: 30133438
Implement Sci. 2020 May 24;15(1):37
pubmed: 32448231
BMJ Glob Health. 2019 Jan 25;4(Suppl 1):e000899
pubmed: 30775017
BMC Public Health. 2015 Sep 18;15:914
pubmed: 26385563
Obes Rev. 2013 Nov;14 Suppl 2:159-68
pubmed: 24103073
Int J Behav Nutr Phys Act. 2018 Jan 17;15(1):8
pubmed: 29343247
Econ Hum Biol. 2020 Aug;38:100869
pubmed: 32442926
Health Res Policy Syst. 2018 May 29;16(1):45
pubmed: 29843743

Auteurs

Julia Stadelmaier (J)

Institute for Evidence in Medicine, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Eva A Rehfuess (EA)

Institute for Medical Information Processing, Biometry and Epidemiology (IBE), LMU Munich, Munich, Germany.
Pettenkofer School of Public Health, Munich, Germany.

Sarah Forberger (S)

Department of Prevention and Evaluation, Leibniz-Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.

Angelika Eisele-Metzger (A)

Institute for Evidence in Medicine, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany.

Blin Nagavci (B)

Institute for Evidence in Medicine, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Holger J Schünemann (HJ)

Department of Health Research Methods, Evidence and Impact, McMaster University, Hamilton, Canada.
Department of Medicine, McMaster University, Hamilton, Canada.

Joerg J Meerpohl (JJ)

Institute for Evidence in Medicine, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Cochrane Germany, Cochrane Germany Foundation, Freiburg, Germany.

Lukas Schwingshackl (L)

Institute for Evidence in Medicine, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH